TRACY SCOTT: Open Payments
NPI 1760921696 · BYHALIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 42 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $916 · 2025 $1,236
Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $352 |
| Lilly USA, LLC | 3 | $237 |
| AstraZeneca Pharmaceuticals LP | 5 | $210 |
| ABBVIE INC. | 10 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| PFIZER INC. | 3 | $59 |
| Braeburn Inc. | 2 | $39 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Antares Pharma, Inc. | 1 | $22 |
Products named: Ozempic, AIRSUPRA, ZEPBOUND, Wegovy, UBRELVY, CAPLYTA, Auvelity, NURTEC ODT.
Industry payments across MS — which companies pay providers there.
